SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?


To: stockman_scott who wrote (184)3/19/2002 12:41:07 PM
From: JEB  Respond to of 544
 
;-)



To: stockman_scott who wrote (184)1/13/2003 3:01:38 PM
From: tuck  Respond to of 544
 
SS,

<<INGN owns a protein in pre-clinical called BAK that destroyed 99.9999999999999% of the breast cancer cells in cell cultures.>>

INGN shows Bak in their preclinical pipeline, but I couldn't find the in vitro study. Got a link?

TIA & Cheers, Tuck